Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
April 27, 2021 5:48 AM 1 min read

Jack Ma's Ant Could See Valuation Drop To As Low As $29B With Changes Forced By Regulations: Report

by Rachit Vats Benzinga Staff Writer
Follow
BABA Logo
BABAAlibaba Group Holding Ltd
$164.25-1.36%
Overview

What Happened: The company’s valuation could drop to a range of $29 billion to $115 billion, from $320 billion in November when the company was forced to scrap its record initial public offering, a Bloomberg report on the matter said. 

The steep fall in valuation is expected as the Chinese company becomes a financial holding firm that’s regulated more like a bank — lowering its revenue growth significantly and profits, according to Chan.

Jack Ma’s Ant and China’s other fintech giants have faced multiple setbacks due to regulatory curbs ranging from online lending to payments, wealth management, and insurance.

See Also: Why Alibaba Just Got Hit With A Record $2.87 Billion Fine In China

Ant’s consumer lending units Huabei and Jiebei could be hit with their links being removed from Alipay, which has at least a billion users.

Ant’s valuation may not top even $75 billion if it is continued to be treated as a traditional lender, as per Chan.

Why It Matters: Alibaba was earlier this month slapped with a record $2.8 billion fine by China’s regulators who after a monopoly probe found that the company had abused its dominant market position.

Alibaba had last year come under the Chinese regulatory spotlight after its co-founder Ma, the country’s most-famed billionaire, made comments that were critical of Chinese regulations at an event in Shanghai in October.

Price Action: Shares of Alibaba closed 0.27% lower at $232.70 on Monday.

Read Next: Alibaba's Ant To Offer Zero-Interest Loans To Some Staffers As It Looks Past Regulatory Troubles: Report

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
FintechGovernmentNewsRegulationsGlobalAnt GroupChinaJack Mapayments

Alibaba Group Holdings Ltd (NYSE:BABA)-backed Ant Group’s valuation could potentially plummet to as low as $29 billion, according to Bloomberg Intelligence analyst Francis Chan.

BABA Logo
BABAAlibaba Group Holding Ltd
$164.25-1.36%
Overview
fintech-banner
Fintech Focus Newsletter
Your update on what's going on in the Fintech space. Keep up-to-date with news, valuations, mergers, funding, and events. Sign up today!
Comments
Loading...